SIMILAR PATTERNS OF AMINO ACIDS FOR 5MTH_A_ACTA302

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)

Filter list by:

	Hit	Macromolecule/ Organism	Pfam	Res.	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ad0	ANTIBODY A5B7 (HEAVY CHAIN) (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 112 ALA B 114 PHE B 146 LEU B 170	None	0.32A	5mthA-1ad0B: 27.3	5mthA-1ad0B: 57.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1cr9	FAB ANTIBODY HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 109 ALA H 111 PHE H 143 LEU H 167	None	0.34A	5mthA-1cr9H: 27.7	5mthA-1cr9H: 71.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ct8	7C8 FAB FRAGMENT LONG CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER B 112 ALA B 114 PHE B 146 LEU B 170 ASP B 173	None	1.01A	5mthA-1ct8B: 30.0	5mthA-1ct8B: 77.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1emt	IGG ANTIBODY (HEAVY CHAIN) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 115 ALA H 117 PHE H 149 LEU H 173 ASP H 176	None	0.55A	5mthA-1emtH: 28.7	5mthA-1emtH: 82.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1fpt	IGG2A-KAPPA C3 FAB (HEAVY CHAIN) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 148 LEU H 178 ASP H 181	None	0.44A	5mthA-1fptH: 28.6	5mthA-1fptH: 79.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1i9i	RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 117 ALA H 119 PHE H 151 LEU H 175	None	0.41A	5mthA-1i9iH: 27.9	5mthA-1i9iH: 72.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1igy	IGG1 INTACT ANTIBODY MAB61.1.3 (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER B 112 ALA B 114 PHE B 148 LEU B 178 ASP B 183	None	1.03A	5mthA-1igyB: 18.8	5mthA-1igyB: 80.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ikf	IGG1-KAPPA R45-45-11 FAB (HEAVY CHAIN) (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 125 ALA H 127 PHE H 159 LEU H 183 ASP H 186	None	0.45A	5mthA-1ikfH: 26.8	5mthA-1ikfH: 68.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1il1	MONOCLONAL ANTIBODY G3-519 (HEAVY CHAIN) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER A 120 ALA A 122 PHE A 154 LEU A 178 ASP A 181	None	0.42A	5mthA-1il1A: 19.4	5mthA-1il1A: 79.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1lk3	9D7 HEAVY CHAIN (Rattus norvegicus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.38A	5mthA-1lk3H: 19.8	5mthA-1lk3H: 76.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1mam	IGG2B-KAPPA YST9.1 FAB (HEAVY CHAIN) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.40A	5mthA-1mamH: 24.5	5mthA-1mamH: 63.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1mj8	IMMUNOGLOBULIN MS6-126 (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 148 LEU H 178 ASP H 183	None	0.49A	5mthA-1mj8H: 28.2	5mthA-1mj8H: 76.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1nld	FAB1583 (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 146 LEU H 170 ASP H 173	None	0.79A	5mthA-1nldH: 26.3	5mthA-1nldH: 64.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1pz5	HEAVY CHAIN OF FAB (SYA/J6) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 112 ALA B 114 PHE B 146 LEU B 170	None	0.36A	5mthA-1pz5B: 26.7	5mthA-1pz5B: 56.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1q0y	FAB 9B1, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 148 LEU H 178 ASP H 183	None	0.82A	5mthA-1q0yH: 23.7	5mthA-1q0yH: 75.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1rfd	FAB M82G2, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 148 LEU H 178 ASP H 181	None	0.60A	5mthA-1rfdH: 26.9	5mthA-1rfdH: 65.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1rur	IMMUNOGLOBULIN 13G5, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 148 LEU H 178	None	0.36A	5mthA-1rurH: 19.4	5mthA-1rurH: 84.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1rz8	FAB 17B HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 112 ALA B 114 PHE B 146 LEU B 170	None	0.35A	5mthA-1rz8B: 17.3	5mthA-1rz8B: 56.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1sbs	MONOCLONAL ANTIBODY 3A2 (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 122 ALA H 124 PHE H 156 LEU H 180 ASP H 183	None	0.69A	5mthA-1sbsH: 26.8	5mthA-1sbsH: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1seq	MONOCLONAL ANTIBODY MNAC13 (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 146 LEU H 170 ASP H 173	None	0.65A	5mthA-1seqH: 27.4	5mthA-1seqH: 70.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1sy6	OKT3 FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.25A	5mthA-1sy6H: 19.0	5mthA-1sy6H: 78.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1t4k	IMMUNOGLOBULIN IGG1, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER B 112 ALA B 114 PHE B 148 LEU B 178 ASP B 183	None	0.42A	5mthA-1t4kB: 27.7	5mthA-1t4kB: 68.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1t66	IMMUNOGLOBULIN HEAVY CHAIN (Mus musculus)	no annotation	4	SER H 117 ALA H 119 PHE H 151 LEU H 175	None	0.30A	5mthA-1t66H: 26.2	5mthA-1t66H: 64.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.41A	5mthA-1um4H: 27.1	5mthA-1um4H: 67.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1vge	TR1.9 FAB (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 121 ALA H 123 PHE H 155 LEU H 179	None	0.40A	5mthA-1vgeH: 27.6	5mthA-1vgeH: 60.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1yed	IGG1 FAB FRAGMENT (D.2.4) (Mus musculus)	no annotation	5	SER H 112 ALA H 116 PHE H 148 LEU H 172 ASP H 175	None	0.66A	5mthA-1yedH: 27.6	5mthA-1yedH: 84.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ztx	HEAVY CHAIN OF E16 ANTIBODY (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 148 LEU H 178	None	0.41A	5mthA-1ztxH: 16.9	5mthA-1ztxH: 74.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ajx	ANTIBODY 7A1 FAB' (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 148 LEU H 178	None	0.24A	5mthA-2ajxH: 19.7	5mthA-2ajxH: 70.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ck0	PROTEIN (IMMUNOGLOBULIN HEAVY CHAIN) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 116 ALA H 118 PHE H 150 LEU H 174 ASP H 177	None	0.68A	5mthA-2ck0H: 27.3	5mthA-2ck0H: 67.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2g2r	GREEN-FLUORESCENT ANTIBODY (11G10)-HEAVY CHAIN (Mus musculus)	no annotation	4	SER H 112 ALA H 114 PHE H 148 LEU H 178	None	0.30A	5mthA-2g2rH: 29.0	5mthA-2g2rH: 73.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2g60	ANTI-FLAG M2 FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 148 LEU H 178 ASP H 183	None	0.34A	5mthA-2g60H: 28.9	5mthA-2g60H: 79.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2mpa	MN12H2 IGG2A-KAPPA,HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 120 ALA H 122 PHE H 154 LEU H 178	None	0.37A	5mthA-2mpaH: 26.5	5mthA-2mpaH: 73.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2or9	MONOCLONAL ANTI-C-MYC ANTIBODY 9E10 (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.32A	5mthA-2or9H: 27.1	5mthA-2or9H: 71.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2oz4	FAB FRAGMENT, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 113 ALA H 115 PHE H 147 LEU H 171 ASP H 174	None	0.35A	5mthA-2oz4H: 27.8	5mthA-2oz4H: 80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2pcp	IMMUNOGLOBULIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER B 112 ALA B 114 PHE B 148 LEU B 178 ASP B 183	None	0.90A	5mthA-2pcpB: 27.1	5mthA-2pcpB: 81.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2r1y	FAB, ANTIBODY FRAGMENT (IGG1K), HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER B 110 ALA B 112 PHE B 144 LEU B 168 ASP B 171	None	0.37A	5mthA-2r1yB: 28.7	5mthA-2r1yB: 70.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2w9d	ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 115 ALA H 117 PHE H 148 LEU H 172 ASP H 175	None	0.33A	5mthA-2w9dH: 28.1	5mthA-2w9dH: 81.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2xqy	A13-D6.3 MONOCLONAL ANTIBODY (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER G 112 ALA G 114 PHE G 146 LEU G 170 ASP G 173	None	0.33A	5mthA-2xqyG: 29.8	5mthA-2xqyG: 73.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2z4q	ANTI EGFR ANTIBODY FAB, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER B 117 ALA B 119 PHE B 151 LEU B 175 ASP B 178	None	0.39A	5mthA-2z4qB: 28.5	5mthA-2z4qB: 75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3d85	FAB OF ANTIBODY 7G10, HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 114 ALA B 116 PHE B 148 LEU B 172	None	0.23A	5mthA-3d85B: 29.1	5mthA-3d85B: 68.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3e8u	FAB 106.3 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 112 ALA H 114 PHE H 148 LEU H 172 ASP H 175	None	0.46A	5mthA-3e8uH: 28.2	5mthA-3e8uH: 69.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3fo0	CATALYTIC ANTIBODY FAB 13G5 IGG2B HEAVY CHAIN CHIMERA (Homo sapiens; Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 120 ALA H 122 PHE H 154 LEU H 178	None	0.29A	5mthA-3fo0H: 26.9	5mthA-3fo0H: 52.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3gnm	JAA-F11 FAB ANTIBODY FRAGMENT, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 117 ALA H 119 PHE H 151 LEU H 175	None	0.35A	5mthA-3gnmH: 30.0	5mthA-3gnmH: 69.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3hns	CS-35 FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 117 ALA H 119 PHE H 151 LEU H 175	None	0.32A	5mthA-3hnsH: 29.4	5mthA-3hnsH: 67.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ijs	IMMUNOGLOBULIN HEAVY CHAIN (IGG3) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 112 ALA B 114 PHE B 146 LEU B 170	None	0.26A	5mthA-3ijsB: 28.3	5mthA-3ijsB: 57.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3iu4	CHP3 FAB HEAVY CHAIN (Homo sapiens; Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.31A	5mthA-3iu4H: 27.0	5mthA-3iu4H: 46.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3l7f	H2L6 HEAVY CHAIN (Homo sapiens)	no annotation	4	SER H 120 ALA H 122 PHE H 154 LEU H 178	None	0.30A	5mthA-3l7fH: 27.2	5mthA-3l7fH: 49.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3qo0	FAB FRAGMENT OF IMMUNOGLOBULIN G1 HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 118 ALA B 120 PHE B 152 LEU B 176	None	0.31A	5mthA-3qo0B: 25.6	5mthA-3qo0B: 53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ra7	FAB FRAGMENT, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 124 ALA H 126 PHE H 158 LEU H 182 ASP H 185	None	0.80A	5mthA-3ra7H: 25.1	5mthA-3ra7H: 69.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3tt3	MOUSE MONOCLONAL 1GG1 FAB FRAGMENT, KAPPA LIGHT CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 118 ALA H 120 PHE H 152 LEU H 176 ASP H 179	None	0.54A	5mthA-3tt3H: 28.8	5mthA-3tt3H: 81.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3uyr	ANTIBODY FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 116 ALA H 118 PHE H 150 LEU H 174	None	0.18A	5mthA-3uyrH: 27.7	5mthA-3uyrH: 62.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3zkm	FAB HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	5	SER C 115 ALA C 117 PHE C 149 LEU C 173 ASP C 176	None	0.37A	5mthA-3zkmC: 27.3	5mthA-3zkmC: 63.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ag4	MONOCLONAL ANTIBODY 3E3 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.40A	5mthA-4ag4H: 28.7	5mthA-4ag4H: 82.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4bz1	FAB 3E31 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 116 ALA H 118 PHE H 150 LEU H 174	None	0.33A	5mthA-4bz1H: 29.0	5mthA-4bz1H: 82.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4d3c	SFN68 FAB (Oryctolagus cuniculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 115 ALA H 117 PHE H 149 LEU H 173	None	0.30A	5mthA-4d3cH: 27.1	5mthA-4d3cH: 55.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4d9q	ANTI-FACTOR D, HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER E 120 ALA E 122 PHE E 154 LEU E 178	None	0.29A	5mthA-4d9qE: 28.6	5mthA-4d9qE: 59.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4edx	HEAVY CHAIN OF FAB OF MURINE ANTI-NGF (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 112 ALA B 114 PHE B 148 LEU B 178	None	0.28A	5mthA-4edxB: 27.4	5mthA-4edxB: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4g6k	HEAVY CHAIN OF GEVOKIZUMAB ANTIBODY BINDING FRAGMENT (Homo sapiens; Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 119 ALA H 121 PHE H 153 LEU H 177	None	0.35A	5mthA-4g6kH: 25.9	5mthA-4g6kH: 53.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4i77	LEBRIKIZUMAB HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.40A	5mthA-4i77H: 18.3	5mthA-4i77H: 50.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4jlr	MOTAVIZUMAB FAB HEAVY CHAIN (Homo sapiens)	no annotation	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.30A	5mthA-4jlrH: 26.8	5mthA-4jlrH: 49.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4jn2	ANTI DABIGATRAN FAB (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 122 ALA B 124 PHE B 156 LEU B 180	None	0.38A	5mthA-4jn2B: 25.3	5mthA-4jn2B: 55.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4kvc	IG HEAVY CHAIN V REGION MOPC 21, IGH PROTEIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 119 ALA H 121 PHE H 153 LEU H 177 ASP H 180	None	0.89A	5mthA-4kvcH: 26.3	5mthA-4kvcH: 65.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4kxz	GC1008 HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 119 ALA H 121 PHE H 153 LEU H 177	None	0.35A	5mthA-4kxzH: 27.1	5mthA-4kxzH: 61.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4l5f	HEAVY CHAIN OF E106 ANTIBODY (VH AND CH1 OF IGG2C) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.20A	5mthA-4l5fH: 30.1	5mthA-4l5fH: 75.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4lri	MSL-109 HEAVY CHAIN (Homo sapiens)	no annotation	4	SER P 129 ALA P 131 PHE P 163 LEU P 187	None	0.32A	5mthA-4lriP: 25.7	5mthA-4lriP: 53.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4m1g	MURINE IGG2A A27D7 HEAVY CHAIN FAB DOMAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 117 ALA H 119 PHE H 151 LEU H 175 ASP H 178	None	1.09A	5mthA-4m1gH: 27.6	5mthA-4m1gH: 61.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4mhh	H5M9 ANTIBODY, HEAVY CHAIN (IGG1) (Mus musculus)	no annotation	5	SER H 112 ALA H 114 PHE H 148 LEU H 178 ASP H 183	None	0.77A	5mthA-4mhhH: 28.2	5mthA-4mhhH: 81.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4nzr	PGT135 HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 148 LEU H 178	None	0.41A	5mthA-4nzrH: 24.6	5mthA-4nzrH: 51.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4o4y	2095-2 HEAVY CHAIN (Homo sapiens; Oryctolagus cuniculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 113 ALA H 115 PHE H 147 LEU H 171	None	0.37A	5mthA-4o4yH: 25.4	5mthA-4o4yH: 52.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4uom	FAB FRAGMENT HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 115 ALA H 117 PHE H 149 LEU H 173	None	0.39A	5mthA-4uomH: 27.6	5mthA-4uomH: 85.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4xzu	3E6 ANTIBODY FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER A 115 ALA A 117 PHE A 149 LEU A 173	None	0.31A	5mthA-4xzuA: 27.2	5mthA-4xzuA: 66.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4yue	S4B6 FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 125 ALA H 127 PHE H 159 LEU H 183	None	0.26A	5mthA-4yueH: 28.0	5mthA-4yueH: 73.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4zxb	FAB 83-7 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER A 117 ALA A 119 PHE A 151 LEU A 175	None	0.41A	5mthA-4zxbA: 28.5	5mthA-4zxbA: 71.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5aum	HEAVY CHAIN OF FAB FRAGMENT (Rattus)	no annotation	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.33A	5mthA-5aumH: 18.4	5mthA-5aumH: 57.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5c0n	FAB CA33 HEAVY CHAIN (Oryctolagus cuniculus)	no annotation	4	SER H 119 ALA H 121 PHE H 153 LEU H 177	None	0.33A	5mthA-5c0nH: 26.9	5mthA-5c0nH: 71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5dq9	S55-3 FAB (IGG2B) HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER A 112 ALA A 114 PHE A 146 LEU A 170	None	0.36A	5mthA-5dq9A: 25.8	5mthA-5dq9A: 65.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5dyo	FAB 43.1 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER A 112 ALA A 114 PHE A 146 LEU A 170	None	0.39A	5mthA-5dyoA: 27.0	5mthA-5dyoA: 78.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ea0	HEAVY CHAIN OF ANTIBODY 7968 FAB FRAGMENT (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 114 ALA H 116 PHE H 148 LEU H 172	None	0.41A	5mthA-5ea0H: 26.9	5mthA-5ea0H: 53.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ebw	ANTIBODY FAB FRAGMENT LIGHT CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER A 117 ALA A 119 PHE A 151 LEU A 175	None	0.33A	5mthA-5ebwA: 28.6	5mthA-5ebwA: 82.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5eoc	FAB FRAGMENT (HEAVY CHAIN) (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 118 ALA H 120 PHE H 150 LEU H 174	None	0.29A	5mthA-5eocH: 29.0	5mthA-5eocH: 81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5eor	ANTI VACCINIA VIRUS A27 ANTIBODY 8E3 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	5	SER H 115 ALA H 117 PHE H 149 LEU H 173 ASP H 176	None	0.55A	5mthA-5eorH: 26.7	5mthA-5eorH: 62.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ezj	FAB C12 HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER A 132 ALA A 134 PHE A 166 LEU A 190	None	0.41A	5mthA-5ezjA: 19.1	5mthA-5ezjA: 66.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5fgc	ANTI-HCV E2 FAB HC33.8 HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER E 126 ALA E 128 PHE E 160 LEU E 184	None	0.39A	5mthA-5fgcE: 26.7	5mthA-5fgcE: 53.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5hdq	FAB HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.29A	5mthA-5hdqH: 30.0	5mthA-5hdqH: 75.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5i73	8B6 ANTIBODY, HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 137 ALA B 139 PHE B 171 LEU B 195	None	0.34A	5mthA-5i73B: 28.3	5mthA-5i73B: 75.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5i8k	HHH1 FAB HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 115 ALA H 117 PHE H 149 LEU H 173	None	0.41A	5mthA-5i8kH: 26.1	5mthA-5i8kH: 52.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5i8o	HMM5 ANTIBODY HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 115 ALA H 117 PHE H 149 LEU H 173	None	0.39A	5mthA-5i8oH: 25.9	5mthA-5i8oH: 50.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5mev	FAB HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.28A	5mthA-5mevH: 26.7	5mthA-5mevH: 70.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5myx	FAB C#24 HEAVY CHAIN (Mus musculus)	PF07654 (C1-set) PF07686 (V-set)	4	SER B 114 ALA B 116 PHE B 148 LEU B 172	None	0.29A	5mthA-5myxB: 29.9	5mthA-5myxB: 86.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5nb5	DESIGN OF ANTIBODIES (Escherichia coli)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 115 ALA H 117 PHE H 149 LEU H 173	None	0.37A	5mthA-5nb5H: 25.0	5mthA-5nb5H: 62.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5o14	FAB 1A12 HEAVY CHAIN (Homo sapiens)	no annotation	4	SER C 121 ALA C 123 PHE C 155 LEU C 179	None	0.38A	5mthA-5o14C: 28.8	5mthA-5o14C: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5obf	FAB HEAVY CHAIN (Mus musculus)	no annotation	4	SER H 111 ALA H 113 PHE H 145 LEU H 169	None	0.28A	5mthA-5obfH: 27.6	5mthA-5obfH: 71.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5v6m	HEAVY CHAIN OF FAB FRAGMENT OF RABBIT ANTI-HIV1 GP120 V3 MAB 10A3 (Oryctolagus cuniculus)	no annotation	4	SER H 108 ALA H 110 PHE H 142 LEU H 166	None	0.39A	5mthA-5v6mH: 26.3	5mthA-5v6mH: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5vgj	VRC38.01 FAB HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.28A	5mthA-5vgjH: 25.4	5mthA-5vgjH: 51.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5vic	FAB HEAVY CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	4	SER H 112 ALA H 114 PHE H 146 LEU H 170	None	0.36A	5mthA-5vicH: 17.2	5mthA-5vicH: 54.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5vxr	MAB24 VARIABLE HEAVY CHAIN,MAB24 VARIABLE HEAVY CHAIN (Mus musculus)	no annotation	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.17A	5mthA-5vxrH: 26.4	5mthA-5vxrH: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6a0x	ANTIBODY 13D4, FAB HEAVY CHAIN (Mus musculus)	no annotation	4	SER A 112 ALA A 114 PHE A 146 LEU A 170	None	0.33A	5mthA-6a0xA: 28.0	5mthA-6a0xA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6aq7	POM6 FAB HEAVY CHAIN (Mus musculus)	no annotation	5	SER H 114 ALA H 116 PHE H 147 LEU H 171 ASP H 174	None	0.28A	5mthA-6aq7H: 29.3	5mthA-6aq7H: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6bli	CB002.5 FAB HEAVY CHAIN (Homo sapiens)	no annotation	4	SER A 112 ALA A 114 PHE A 146 LEU A 170	None	0.30A	5mthA-6bliA: 26.3	5mthA-6bliA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6eyn	- (-)	no annotation	4	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.31A	5mthA-6eynH: 17.6	5mthA-6eynH: undetectable

[["5MTH_A_ACTA302_0","1ad0","Homo sapiens","ANTIBODY A5B7 (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",4,"SER B 112;ALA B 114;PHE B 146;LEU B 170","None","0.32A","5mthA-1ad0B:27.3","5mthA-1ad0B:57.66"],["5MTH_A_ACTA302_0","1cr9","Mus musculus","FAB ANTIBODY HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 109;ALA H 111;PHE H 143;LEU H 167","None","0.34A","5mthA-1cr9H:27.7","5mthA-1cr9H:71.95"],["5MTH_A_ACTA302_0","1ct8","Mus musculus","7C8 FAB FRAGMENT; LONG CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER B 112;ALA B 114;PHE B 146;LEU B 170;ASP B 173","None","1.01A","5mthA-1ct8B:30.0","5mthA-1ct8B:77.38"],["5MTH_A_ACTA302_0","1emt","Mus musculus","IGG ANTIBODY (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",5,"SER H 115;ALA H 117;PHE H 149;LEU H 173;ASP H 176","None","0.55A","5mthA-1emtH:28.7","5mthA-1emtH:82.73"],["5MTH_A_ACTA302_0","1fpt","Mus musculus","IGG2A-KAPPA C3 FAB (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 148;LEU H 178;ASP H 181","None","0.44A","5mthA-1fptH:28.6","5mthA-1fptH:79.09"],["5MTH_A_ACTA302_0","1i9i","Mus musculus","RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB FRAGMENT HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 117;ALA H 119;PHE H 151;LEU H 175","None","0.41A","5mthA-1i9iH:27.9","5mthA-1i9iH:72.85"],["5MTH_A_ACTA302_0","1igy","Mus musculus","IGG1 INTACT ANTIBODY MAB61.1.3","PF07654(C1-set);PF07686(V-set)",5,"SER B 112;ALA B 114;PHE B 148;LEU B 178;ASP B 183","None","1.03A","5mthA-1igyB:18.8","5mthA-1igyB:80.45"],["5MTH_A_ACTA302_0","1ikf","Homo sapiens","IGG1-KAPPA R45-45-11 FAB (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",5,"SER H 125;ALA H 127;PHE H 159;LEU H 183;ASP H 186","None","0.45A","5mthA-1ikfH:26.8","5mthA-1ikfH:68.56"],["5MTH_A_ACTA302_0","1il1","Mus musculus","MONOCLONAL ANTIBODY G3-519 (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",5,"SER A 120;ALA A 122;PHE A 154;LEU A 178;ASP A 181","None","0.42A","5mthA-1il1A:19.4","5mthA-1il1A:79.82"],["5MTH_A_ACTA302_0","1lk3","Rattus norvegicus","9D7 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.38A","5mthA-1lk3H:19.8","5mthA-1lk3H:76.36"],["5MTH_A_ACTA302_0","1mam","Mus musculus","IGG2B-KAPPA YST9.1 FAB (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.40A","5mthA-1mamH:24.5","5mthA-1mamH:63.64"],["5MTH_A_ACTA302_0","1mj8","Mus musculus","IMMUNOGLOBULIN MS6-126","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 148;LEU H 178;ASP H 183","None","0.49A","5mthA-1mj8H:28.2","5mthA-1mj8H:76.47"],["5MTH_A_ACTA302_0","1nld","Mus musculus","FAB1583","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 146;LEU H 170;ASP H 173","None","0.79A","5mthA-1nldH:26.3","5mthA-1nldH:64.25"],["5MTH_A_ACTA302_0","1pz5","Mus musculus","HEAVY CHAIN OF FAB (SYA\/J6)","PF07654(C1-set);PF07686(V-set)",4,"SER B 112;ALA B 114;PHE B 146;LEU B 170","None","0.36A","5mthA-1pz5B:26.7","5mthA-1pz5B:56.70"],["5MTH_A_ACTA302_0","1q0y","Mus musculus","FAB 9B1, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 148;LEU H 178;ASP H 183","None","0.82A","5mthA-1q0yH:23.7","5mthA-1q0yH:75.22"],["5MTH_A_ACTA302_0","1rfd","Mus musculus","FAB M82G2, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 148;LEU H 178;ASP H 181","None","0.60A","5mthA-1rfdH:26.9","5mthA-1rfdH:65.78"],["5MTH_A_ACTA302_0","1rur","Mus musculus","IMMUNOGLOBULIN 13G5, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 148;LEU H 178","None","0.36A","5mthA-1rurH:19.4","5mthA-1rurH:84.47"],["5MTH_A_ACTA302_0","1rz8","Homo sapiens","FAB 17B HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER B 112;ALA B 114;PHE B 146;LEU B 170","None","0.35A","5mthA-1rz8B:17.3","5mthA-1rz8B:56.14"],["5MTH_A_ACTA302_0","1sbs","Mus musculus","MONOCLONAL ANTIBODY 3A2","PF07654(C1-set);PF07686(V-set)",5,"SER H 122;ALA H 124;PHE H 156;LEU H 180;ASP H 183","None","0.69A","5mthA-1sbsH:26.8","5mthA-1sbsH:69.82"],["5MTH_A_ACTA302_0","1seq","Mus musculus","MONOCLONAL ANTIBODY MNAC13","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 146;LEU H 170;ASP H 173","None","0.65A","5mthA-1seqH:27.4","5mthA-1seqH:70.98"],["5MTH_A_ACTA302_0","1sy6","Mus musculus","OKT3 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.25A","5mthA-1sy6H:19.0","5mthA-1sy6H:78.64"],["5MTH_A_ACTA302_0","1t4k","Mus musculus","IMMUNOGLOBULIN IGG1, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER B 112;ALA B 114;PHE B 148;LEU B 178;ASP B 183","None","0.42A","5mthA-1t4kB:27.7","5mthA-1t4kB:68.64"],["5MTH_A_ACTA302_0","1t66","Mus musculus","IMMUNOGLOBULIN HEAVY CHAIN","no annotation",4,"SER H 117;ALA H 119;PHE H 151;LEU H 175","None","0.30A","5mthA-1t66H:26.2","5mthA-1t66H:64.13"],["5MTH_A_ACTA302_0","1um4","Mus musculus","ANTIBODY 21H3 H CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.41A","5mthA-1um4H:27.1","5mthA-1um4H:67.58"],["5MTH_A_ACTA302_0","1vge","Homo sapiens","TR1.9 FAB","PF07654(C1-set);PF07686(V-set)",4,"SER H 121;ALA H 123;PHE H 155;LEU H 179","None","0.40A","5mthA-1vgeH:27.6","5mthA-1vgeH:60.71"],["5MTH_A_ACTA302_0","1yed","Mus musculus","IGG1 FAB FRAGMENT (D.2.4)","no annotation",5,"SER H 112;ALA H 116;PHE H 148;LEU H 172;ASP H 175","None","0.66A","5mthA-1yedH:27.6","5mthA-1yedH:84.44"],["5MTH_A_ACTA302_0","1ztx","Mus musculus","HEAVY CHAIN OF E16 ANTIBODY","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 148;LEU H 178","None","0.41A","5mthA-1ztxH:16.9","5mthA-1ztxH:74.09"],["5MTH_A_ACTA302_0","2ajx","Mus musculus","ANTIBODY 7A1 FAB'","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 148;LEU H 178","None","0.24A","5mthA-2ajxH:19.7","5mthA-2ajxH:70.72"],["5MTH_A_ACTA302_0","2ck0","Mus musculus","PROTEIN (IMMUNOGLOBULIN; HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",5,"SER H 116;ALA H 118;PHE H 150;LEU H 174;ASP H 177","None","0.68A","5mthA-2ck0H:27.3","5mthA-2ck0H:67.71"],["5MTH_A_ACTA302_0","2g2r","Mus musculus","GREEN-FLUORESCENT ANTIBODY (11G10)-HEAVY CHAIN","no annotation",4,"SER H 112;ALA H 114;PHE H 148;LEU H 178","None","0.30A","5mthA-2g2rH:29.0","5mthA-2g2rH:73.99"],["5MTH_A_ACTA302_0","2g60","Mus musculus","ANTI-FLAG M2 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 148;LEU H 178;ASP H 183","None","0.34A","5mthA-2g60H:28.9","5mthA-2g60H:79.82"],["5MTH_A_ACTA302_0","2mpa","Mus musculus","MN12H2 IGG2A-KAPPA,HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 120;ALA H 122;PHE H 154;LEU H 178","None","0.37A","5mthA-2mpaH:26.5","5mthA-2mpaH:73.42"],["5MTH_A_ACTA302_0","2or9","Mus musculus","MONOCLONAL ANTI-C-MYC ANTIBODY 9E10","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.32A","5mthA-2or9H:27.1","5mthA-2or9H:71.93"],["5MTH_A_ACTA302_0","2oz4","Mus musculus","FAB FRAGMENT, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 113;ALA H 115;PHE H 147;LEU H 171;ASP H 174","None","0.35A","5mthA-2oz4H:27.8","5mthA-2oz4H:80.00"],["5MTH_A_ACTA302_0","2pcp","Mus musculus","IMMUNOGLOBULIN","PF07654(C1-set);PF07686(V-set)",5,"SER B 112;ALA B 114;PHE B 148;LEU B 178;ASP B 183","None","0.90A","5mthA-2pcpB:27.1","5mthA-2pcpB:81.19"],["5MTH_A_ACTA302_0","2r1y","Mus musculus","FAB, ANTIBODY FRAGMENT (IGG1K), HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER B 110;ALA B 112;PHE B 144;LEU B 168;ASP B 171","None","0.37A","5mthA-2r1yB:28.7","5mthA-2r1yB:70.27"],["5MTH_A_ACTA302_0","2w9d","Mus musculus","ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 115;ALA H 117;PHE H 148;LEU H 172;ASP H 175","None","0.33A","5mthA-2w9dH:28.1","5mthA-2w9dH:81.36"],["5MTH_A_ACTA302_0","2xqy","Mus musculus","A13-D6.3 MONOCLONAL ANTIBODY","PF07654(C1-set);PF07686(V-set)",5,"SER G 112;ALA G 114;PHE G 146;LEU G 170;ASP G 173","None","0.33A","5mthA-2xqyG:29.8","5mthA-2xqyG:73.36"],["5MTH_A_ACTA302_0","2z4q","Mus musculus","ANTI EGFR ANTIBODY FAB, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER B 117;ALA B 119;PHE B 151;LEU B 175;ASP B 178","None","0.39A","5mthA-2z4qB:28.5","5mthA-2z4qB:75.00"],["5MTH_A_ACTA302_0","3d85","Homo sapiens","FAB OF ANTIBODY 7G10, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER B 114;ALA B 116;PHE B 148;LEU B 172","None","0.23A","5mthA-3d85B:29.1","5mthA-3d85B:68.75"],["5MTH_A_ACTA302_0","3e8u","Mus musculus","FAB 106.3 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 112;ALA H 114;PHE H 148;LEU H 172;ASP H 175","None","0.46A","5mthA-3e8uH:28.2","5mthA-3e8uH:69.82"],["5MTH_A_ACTA302_0","3fo0","Homo sapiens;Mus musculus","CATALYTIC ANTIBODY FAB 13G5 IGG2B HEAVY CHAIN CHIMERA","PF07654(C1-set);PF07686(V-set)",4,"SER H 120;ALA H 122;PHE H 154;LEU H 178","None","0.29A","5mthA-3fo0H:26.9","5mthA-3fo0H:52.21"],["5MTH_A_ACTA302_0","3gnm","Mus musculus","JAA-F11 FAB ANTIBODY FRAGMENT, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 117;ALA H 119;PHE H 151;LEU H 175","None","0.35A","5mthA-3gnmH:30.0","5mthA-3gnmH:69.68"],["5MTH_A_ACTA302_0","3hns","Mus musculus","CS-35 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 117;ALA H 119;PHE H 151;LEU H 175","None","0.32A","5mthA-3hnsH:29.4","5mthA-3hnsH:67.42"],["5MTH_A_ACTA302_0","3ijs","Mus musculus","IMMUNOGLOBULIN HEAVY CHAIN (IGG3)","PF07654(C1-set);PF07686(V-set)",4,"SER B 112;ALA B 114;PHE B 146;LEU B 170","None","0.26A","5mthA-3ijsB:28.3","5mthA-3ijsB:57.46"],["5MTH_A_ACTA302_0","3iu4","Homo sapiens;Mus musculus","CHP3 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.31A","5mthA-3iu4H:27.0","5mthA-3iu4H:46.51"],["5MTH_A_ACTA302_0","3l7f","Homo sapiens","H2L6 HEAVY CHAIN","no annotation",4,"SER H 120;ALA H 122;PHE H 154;LEU H 178","None","0.30A","5mthA-3l7fH:27.2","5mthA-3l7fH:49.11"],["5MTH_A_ACTA302_0","3qo0","Homo sapiens","FAB FRAGMENT OF IMMUNOGLOBULIN G1 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER B 118;ALA B 120;PHE B 152;LEU B 176","None","0.31A","5mthA-3qo0B:25.6","5mthA-3qo0B:53.33"],["5MTH_A_ACTA302_0","3ra7","Mus musculus","FAB FRAGMENT, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 124;ALA H 126;PHE H 158;LEU H 182;ASP H 185","None","0.80A","5mthA-3ra7H:25.1","5mthA-3ra7H:69.91"],["5MTH_A_ACTA302_0","3tt3","Mus musculus","MOUSE MONOCLONAL 1GG1 FAB FRAGMENT, KAPPA LIGHT CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 118;ALA H 120;PHE H 152;LEU H 176;ASP H 179","None","0.54A","5mthA-3tt3H:28.8","5mthA-3tt3H:81.90"],["5MTH_A_ACTA302_0","3uyr","Mus musculus","ANTIBODY FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 116;ALA H 118;PHE H 150;LEU H 174","None","0.18A","5mthA-3uyrH:27.7","5mthA-3uyrH:62.56"],["5MTH_A_ACTA302_0","3zkm","Homo sapiens","FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER C 115;ALA C 117;PHE C 149;LEU C 173;ASP C 176","None","0.37A","5mthA-3zkmC:27.3","5mthA-3zkmC:63.35"],["5MTH_A_ACTA302_0","4ag4","Mus musculus","MONOCLONAL ANTIBODY 3E3 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.40A","5mthA-4ag4H:28.7","5mthA-4ag4H:82.65"],["5MTH_A_ACTA302_0","4bz1","Mus musculus","FAB 3E31 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 116;ALA H 118;PHE H 150;LEU H 174","None","0.33A","5mthA-4bz1H:29.0","5mthA-4bz1H:82.27"],["5MTH_A_ACTA302_0","4d3c","Oryctolagus cuniculus","SFN68 FAB","PF07654(C1-set);PF07686(V-set)",4,"SER H 115;ALA H 117;PHE H 149;LEU H 173","None","0.30A","5mthA-4d3cH:27.1","5mthA-4d3cH:55.86"],["5MTH_A_ACTA302_0","4d9q","Homo sapiens","ANTI-FACTOR D, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER E 120;ALA E 122;PHE E 154;LEU E 178","None","0.29A","5mthA-4d9qE:28.6","5mthA-4d9qE:59.91"],["5MTH_A_ACTA302_0","4edx","Mus musculus","HEAVY CHAIN OF FAB OF MURINE ANTI-NGF","PF07654(C1-set);PF07686(V-set)",4,"SER B 112;ALA B 114;PHE B 148;LEU B 178","None","0.28A","5mthA-4edxB:27.4","5mthA-4edxB:63.51"],["5MTH_A_ACTA302_0","4g6k","Homo sapiens;Mus musculus","HEAVY CHAIN OF GEVOKIZUMAB ANTIBODY BINDING FRAGMENT","PF07654(C1-set);PF07686(V-set)",4,"SER H 119;ALA H 121;PHE H 153;LEU H 177","None","0.35A","5mthA-4g6kH:25.9","5mthA-4g6kH:53.15"],["5MTH_A_ACTA302_0","4i77","Homo sapiens","LEBRIKIZUMAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.40A","5mthA-4i77H:18.3","5mthA-4i77H:50.90"],["5MTH_A_ACTA302_0","4jlr","Homo sapiens","MOTAVIZUMAB FAB HEAVY CHAIN","no annotation",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.30A","5mthA-4jlrH:26.8","5mthA-4jlrH:49.56"],["5MTH_A_ACTA302_0","4jn2","Mus musculus","ANTI DABIGATRAN FAB","PF07654(C1-set);PF07686(V-set)",4,"SER B 122;ALA B 124;PHE B 156;LEU B 180","None","0.38A","5mthA-4jn2B:25.3","5mthA-4jn2B:55.11"],["5MTH_A_ACTA302_0","4kvc","Mus musculus","IG HEAVY CHAIN V REGION MOPC 21, IGH PROTEIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 119;ALA H 121;PHE H 153;LEU H 177;ASP H 180","None","0.89A","5mthA-4kvcH:26.3","5mthA-4kvcH:65.00"],["5MTH_A_ACTA302_0","4kxz","Homo sapiens","GC1008 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 119;ALA H 121;PHE H 153;LEU H 177","None","0.35A","5mthA-4kxzH:27.1","5mthA-4kxzH:61.26"],["5MTH_A_ACTA302_0","4l5f","Mus musculus","HEAVY CHAIN OF E106 ANTIBODY (VH AND CH1 OF IGG2C)","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.20A","5mthA-4l5fH:30.1","5mthA-4l5fH:75.57"],["5MTH_A_ACTA302_0","4lri","Homo sapiens","MSL-109 HEAVY CHAIN","no annotation",4,"SER P 129;ALA P 131;PHE P 163;LEU P 187","None","0.32A","5mthA-4lriP:25.7","5mthA-4lriP:53.45"],["5MTH_A_ACTA302_0","4m1g","Mus musculus","MURINE IGG2A A27D7 HEAVY CHAIN FAB DOMAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 117;ALA H 119;PHE H 151;LEU H 175;ASP H 178","None","1.09A","5mthA-4m1gH:27.6","5mthA-4m1gH:61.61"],["5MTH_A_ACTA302_0","4mhh","Mus musculus","H5M9 ANTIBODY, HEAVY CHAIN (IGG1)","no annotation",5,"SER H 112;ALA H 114;PHE H 148;LEU H 178;ASP H 183","None","0.77A","5mthA-4mhhH:28.2","5mthA-4mhhH:81.45"],["5MTH_A_ACTA302_0","4nzr","Homo sapiens","PGT135 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 148;LEU H 178","None","0.41A","5mthA-4nzrH:24.6","5mthA-4nzrH:51.06"],["5MTH_A_ACTA302_0","4o4y","Homo sapiens;Oryctolagus cuniculus","2095-2 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 113;ALA H 115;PHE H 147;LEU H 171","None","0.37A","5mthA-4o4yH:25.4","5mthA-4o4yH:52.68"],["5MTH_A_ACTA302_0","4uom","Homo sapiens","FAB FRAGMENT HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 115;ALA H 117;PHE H 149;LEU H 173","None","0.39A","5mthA-4uomH:27.6","5mthA-4uomH:85.97"],["5MTH_A_ACTA302_0","4xzu","Mus musculus","3E6 ANTIBODY FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER A 115;ALA A 117;PHE A 149;LEU A 173","None","0.31A","5mthA-4xzuA:27.2","5mthA-4xzuA:66.52"],["5MTH_A_ACTA302_0","4yue","Mus musculus","S4B6 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 125;ALA H 127;PHE H 159;LEU H 183","None","0.26A","5mthA-4yueH:28.0","5mthA-4yueH:73.89"],["5MTH_A_ACTA302_0","4zxb","Mus musculus","FAB 83-7 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER A 117;ALA A 119;PHE A 151;LEU A 175","None","0.41A","5mthA-4zxbA:28.5","5mthA-4zxbA:71.49"],["5MTH_A_ACTA302_0","5aum","Rattus","HEAVY CHAIN OF FAB FRAGMENT","no annotation",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.33A","5mthA-5aumH:18.4","5mthA-5aumH:57.02"],["5MTH_A_ACTA302_0","5c0n","Oryctolagus cuniculus","FAB CA33 HEAVY CHAIN","no annotation",4,"SER H 119;ALA H 121;PHE H 153;LEU H 177","None","0.33A","5mthA-5c0nH:26.9","5mthA-5c0nH:71.11"],["5MTH_A_ACTA302_0","5dq9","Mus musculus","S55-3 FAB (IGG2B) HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER A 112;ALA A 114;PHE A 146;LEU A 170","None","0.36A","5mthA-5dq9A:25.8","5mthA-5dq9A:65.32"],["5MTH_A_ACTA302_0","5dyo","Mus musculus","FAB 43.1 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER A 112;ALA A 114;PHE A 146;LEU A 170","None","0.39A","5mthA-5dyoA:27.0","5mthA-5dyoA:78.08"],["5MTH_A_ACTA302_0","5ea0","Homo sapiens","HEAVY CHAIN OF ANTIBODY 7968 FAB FRAGMENT","PF07654(C1-set);PF07686(V-set)",4,"SER H 114;ALA H 116;PHE H 148;LEU H 172","None","0.41A","5mthA-5ea0H:26.9","5mthA-5ea0H:53.10"],["5MTH_A_ACTA302_0","5ebw","Mus musculus","ANTIBODY FAB FRAGMENT LIGHT CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER A 117;ALA A 119;PHE A 151;LEU A 175","None","0.33A","5mthA-5ebwA:28.6","5mthA-5ebwA:82.73"],["5MTH_A_ACTA302_0","5eoc","Mus musculus","FAB FRAGMENT (HEAVY CHAIN)","PF07654(C1-set);PF07686(V-set)",4,"SER H 118;ALA H 120;PHE H 150;LEU H 174","None","0.29A","5mthA-5eocH:29.0","5mthA-5eocH:81.82"],["5MTH_A_ACTA302_0","5eor","Mus musculus","ANTI VACCINIA VIRUS A27 ANTIBODY 8E3 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",5,"SER H 115;ALA H 117;PHE H 149;LEU H 173;ASP H 176","None","0.55A","5mthA-5eorH:26.7","5mthA-5eorH:62.90"],["5MTH_A_ACTA302_0","5ezj","Homo sapiens","FAB C12 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER A 132;ALA A 134;PHE A 166;LEU A 190","None","0.41A","5mthA-5ezjA:19.1","5mthA-5ezjA:66.97"],["5MTH_A_ACTA302_0","5fgc","Homo sapiens","ANTI-HCV E2 FAB HC33.8 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER E 126;ALA E 128;PHE E 160;LEU E 184","None","0.39A","5mthA-5fgcE:26.7","5mthA-5fgcE:53.68"],["5MTH_A_ACTA302_0","5hdq","Mus musculus","FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.29A","5mthA-5hdqH:30.0","5mthA-5hdqH:75.45"],["5MTH_A_ACTA302_0","5i73","Mus musculus","8B6 ANTIBODY, HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER B 137;ALA B 139;PHE B 171;LEU B 195","None","0.34A","5mthA-5i73B:28.3","5mthA-5i73B:75.56"],["5MTH_A_ACTA302_0","5i8k","Homo sapiens","HHH1 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 115;ALA H 117;PHE H 149;LEU H 173","None","0.41A","5mthA-5i8kH:26.1","5mthA-5i8kH:52.68"],["5MTH_A_ACTA302_0","5i8o","Homo sapiens","HMM5 ANTIBODY HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 115;ALA H 117;PHE H 149;LEU H 173","None","0.39A","5mthA-5i8oH:25.9","5mthA-5i8oH:50.89"],["5MTH_A_ACTA302_0","5mev","Homo sapiens","FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.28A","5mthA-5mevH:26.7","5mthA-5mevH:70.14"],["5MTH_A_ACTA302_0","5myx","Mus musculus","FAB C#24 HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER B 114;ALA B 116;PHE B 148;LEU B 172","None","0.29A","5mthA-5myxB:29.9","5mthA-5myxB:86.43"],["5MTH_A_ACTA302_0","5nb5","Escherichia coli","DESIGN OF ANTIBODIES","PF07654(C1-set);PF07686(V-set)",4,"SER H 115;ALA H 117;PHE H 149;LEU H 173","None","0.37A","5mthA-5nb5H:25.0","5mthA-5nb5H:62.05"],["5MTH_A_ACTA302_0","5o14","Homo sapiens","FAB 1A12 HEAVY CHAIN","no annotation",4,"SER C 121;ALA C 123;PHE C 155;LEU C 179","None","0.38A","5mthA-5o14C:28.8","5mthA-5o14C:undetectable"],["5MTH_A_ACTA302_0","5obf","Mus musculus","FAB HEAVY CHAIN","no annotation",4,"SER H 111;ALA H 113;PHE H 145;LEU H 169","None","0.28A","5mthA-5obfH:27.6","5mthA-5obfH:71.95"],["5MTH_A_ACTA302_0","5v6m","Oryctolagus cuniculus","HEAVY CHAIN OF FAB FRAGMENT OF RABBIT ANTI-HIV1 GP120 V3 MAB 10A3","no annotation",4,"SER H 108;ALA H 110;PHE H 142;LEU H 166","None","0.39A","5mthA-5v6mH:26.3","5mthA-5v6mH:undetectable"],["5MTH_A_ACTA302_0","5vgj","Homo sapiens","VRC38.01 FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.28A","5mthA-5vgjH:25.4","5mthA-5vgjH:51.05"],["5MTH_A_ACTA302_0","5vic","Homo sapiens","FAB HEAVY CHAIN","PF07654(C1-set);PF07686(V-set)",4,"SER H 112;ALA H 114;PHE H 146;LEU H 170","None","0.36A","5mthA-5vicH:17.2","5mthA-5vicH:54.42"],["5MTH_A_ACTA302_0","5vxr","Mus musculus","MAB24 VARIABLE HEAVY CHAIN,MAB24 VARIABLE HEAVY CHAIN","no annotation",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.17A","5mthA-5vxrH:26.4","5mthA-5vxrH:undetectable"],["5MTH_A_ACTA302_0","6a0x","Mus musculus","ANTIBODY 13D4, FAB HEAVY CHAIN","no annotation",4,"SER A 112;ALA A 114;PHE A 146;LEU A 170","None","0.33A","5mthA-6a0xA:28.0","5mthA-6a0xA:undetectable"],["5MTH_A_ACTA302_0","6aq7","Mus musculus","POM6 FAB HEAVY CHAIN","no annotation",5,"SER H 114;ALA H 116;PHE H 147;LEU H 171;ASP H 174","None","0.28A","5mthA-6aq7H:29.3","5mthA-6aq7H:undetectable"],["5MTH_A_ACTA302_0","6bli","Homo sapiens","CB002.5 FAB HEAVY CHAIN","no annotation",4,"SER A 112;ALA A 114;PHE A 146;LEU A 170","None","0.30A","5mthA-6bliA:26.3","5mthA-6bliA:undetectable"],["5MTH_A_ACTA302_0","6eyn","-","-","no annotation",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.31A","5mthA-6eynH:17.6","5mthA-6eynH:undetectable"]]